Adult Attention-Deficit/Hyperactivity Disorder : a Narrative Review of Biological Mechanisms, Treatments, and Outcomes
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..
PURPOSE OF REVIEW: Attention-deficit/hyperactivity disorder (ADHD) is a heterogeneous and complex neurodevelopmental disorder related to disruptions in various neuronal structures and pathways, dopamine (DA) transporter, and receptor genes, resulting in cognitive and regulation deficits. This article reviews recent research on the biological mechanisms and markers, clinical manifestations, treatments, and outcomes of adult ADHD as well as current controversies within the field.
RECENT FINDINGS: New research identifies white matter disruptions in multiple cortical pathways in adults with ADHD. New treatments for ADHD in adults such as viloxazine ER have shown preliminary effectiveness in addition to research showing transcranial direct current stimulation can be an effective treatment for adults with ADHD. Although questions exist about the effectiveness of current assessments of and treatments for adult ADHD, recent findings represent a step towards improving the quality of life and outcomes for individuals experiencing this life-long, chronic health condition.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
Current neurology and neuroscience reports - 23(2023), 8 vom: 19. Aug., Seite 451-460 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pagán, Antonio F [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ADHD |
|---|
| Anmerkungen: |
Date Completed 28.07.2023 Date Revised 30.07.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s11910-023-01280-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358370043 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358370043 | ||
| 003 | DE-627 | ||
| 005 | 20231226074609.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11910-023-01280-4 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1194.xml |
| 035 | |a (DE-627)NLM358370043 | ||
| 035 | |a (NLM)37335460 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pagán, Antonio F |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Adult Attention-Deficit/Hyperactivity Disorder |b a Narrative Review of Biological Mechanisms, Treatments, and Outcomes |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.07.2023 | ||
| 500 | |a Date Revised 30.07.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. | ||
| 520 | |a PURPOSE OF REVIEW: Attention-deficit/hyperactivity disorder (ADHD) is a heterogeneous and complex neurodevelopmental disorder related to disruptions in various neuronal structures and pathways, dopamine (DA) transporter, and receptor genes, resulting in cognitive and regulation deficits. This article reviews recent research on the biological mechanisms and markers, clinical manifestations, treatments, and outcomes of adult ADHD as well as current controversies within the field | ||
| 520 | |a RECENT FINDINGS: New research identifies white matter disruptions in multiple cortical pathways in adults with ADHD. New treatments for ADHD in adults such as viloxazine ER have shown preliminary effectiveness in addition to research showing transcranial direct current stimulation can be an effective treatment for adults with ADHD. Although questions exist about the effectiveness of current assessments of and treatments for adult ADHD, recent findings represent a step towards improving the quality of life and outcomes for individuals experiencing this life-long, chronic health condition | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a ADHD | |
| 650 | 4 | |a Adult | |
| 650 | 4 | |a Assessment | |
| 650 | 4 | |a Neurodevelopmental disorders | |
| 650 | 4 | |a Neuropsychology | |
| 650 | 4 | |a Treatment | |
| 700 | 1 | |a Huizar, Yazmine P |e verfasserin |4 aut | |
| 700 | 1 | |a Short, Tucker R |e verfasserin |4 aut | |
| 700 | 1 | |a Gotcher, Zoe |e verfasserin |4 aut | |
| 700 | 1 | |a Schmidt, Adam T |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current neurology and neuroscience reports |d 2001 |g 23(2023), 8 vom: 19. Aug., Seite 451-460 |w (DE-627)NLM117820210 |x 1534-6293 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2023 |g number:8 |g day:19 |g month:08 |g pages:451-460 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11910-023-01280-4 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2023 |e 8 |b 19 |c 08 |h 451-460 | ||